Literature DB >> 22392135

Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents.

D E Said1, L M Elsamad, Y M Gohar.   

Abstract

This study was carried out to evaluate the anti parasitic potential of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents. Non-treated infected control rats were inoculated with Giardia lamblia cysts in a dose of 2 × 10(5) cysts/rat. Experimental group was infected then treated with curcumin, curcumin nanoparticles, chitosan, chitosan nanoparticles, and silver nanoparticles as single or combined therapy. The number of Giardia cysts in stools and trophozoites in intestinal sections were detected. Toxicity of nanoparticles was evaluated by comparing hematological and histopathological parameters of the normal control group and treated non-infected control group. The amount of silver was also measured in the liver, kidney, small intestine, lung, and brain of rats treated with silver nanoparticles. The number of the parasites in stool and small intestinal sections decreased in treated infected rats compared with infected non-treated ones. The effect in the single therapy was better with nanoparticles, and the best effect was detected in nano-silver. The combined therapy gave better results than single. Combination between nanoparticles was better than the combination of nano-forms and native chitosan and curcumin. The best effect was detected in combinations of nano-silver and nano-chitosan but with no full eradication. In conclusion, the highest effect and complete cure was gained by combining the three nano-forms. The parasite was successfully eradicated from stool and intestine. None of the treatments exhibited any toxicity. Accumulated silver in different organs was within the safe limits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392135     DOI: 10.1007/s00436-012-2866-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  62 in total

1.  Antifungal efficacy of chitosan and its thiourea derivatives upon the growth of some sugar-beet pathogens.

Authors:  M Eweis; S S Elkholy; M Z Elsabee
Journal:  Int J Biol Macromol       Date:  2006-01-18       Impact factor: 6.953

2.  Trypanocidal effects of curcumin in vitro.

Authors:  M Nose; T Koide; Y Ogihara; Y Yabu; N Ohta
Journal:  Biol Pharm Bull       Date:  1998-06       Impact factor: 2.233

3.  Latent activity of curcumin against leishmaniasis in vitro.

Authors:  Danish Saleheen; Syed Atif Ali; Khalid Ashfaq; Anwar Al Siddiqui; Ajmal Agha; Muhammad Masoom Yasinzai
Journal:  Biol Pharm Bull       Date:  2002-03       Impact factor: 2.233

4.  Studies on the effectiveness of diarylheptanoids derivatives against Leishmania amazonensis.

Authors:  C A Araujo; L V Alegrio; D C Gomes; M E Lima; L Gomes-Cardoso; L L Leon
Journal:  Mem Inst Oswaldo Cruz       Date:  1999 Nov-Dec       Impact factor: 2.743

5.  Central nervous system toxicity associated with metronidazole therapy.

Authors:  R K Kusumi; J F Plouffe; R H Wyatt; R J Fass
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

6.  Fabrication of silver nanocomposite films impregnated with curcumin for superior antibacterial applications.

Authors:  K Varaprasad; K Vimala; S Ravindra; N Narayana Reddy; G Venkata Subba Reddy; K Mohana Raju
Journal:  J Mater Sci Mater Med       Date:  2011-06-18       Impact factor: 3.896

7.  Effect of ivermectin on combined intestinal protozoal infection (giardiasis and cryptosporidiosis).

Authors:  M Y Youssef; M M Essa; H A Sadaka; M M Eissa; A M Rizk
Journal:  J Egypt Soc Parasitol       Date:  1996-12

8.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

9.  Subchronic oral toxicity of silver nanoparticles.

Authors:  Yong Soon Kim; Moon Yong Song; Jung Duck Park; Kyung Seuk Song; Hyeon Ryol Ryu; Yong Hyun Chung; Hee Kyung Chang; Ji Hyun Lee; Kyung Hui Oh; Bruce J Kelman; In Koo Hwang; Il Je Yu
Journal:  Part Fibre Toxicol       Date:  2010-08-06       Impact factor: 9.400

10.  The synthesis of chitosan-based silver nanoparticles and their antibacterial activity.

Authors:  Dongwei Wei; Wuyong Sun; Weiping Qian; Yongzhong Ye; Xiaoyuan Ma
Journal:  Carbohydr Res       Date:  2009-09-04       Impact factor: 2.104

View more
  26 in total

1.  Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba.

Authors:  Marcin Padzik; Edyta B Hendiger; Lidia Chomicz; Marta Grodzik; Maciej Szmidt; Jarosław Grobelny; Jacob Lorenzo-Morales
Journal:  Parasitol Res       Date:  2018-08-15       Impact factor: 2.289

2.  Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.

Authors:  Shahira A Ahmed; Heba S El-Mahallawy; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

3.  Evaluation of the therapeutic efficacy of albendazole-loaded silver nanoparticles against Echinococcus granulosus infection in experimental mice.

Authors:  Nashaat E Nassef; Abdel-Gawad E Saad; Nancy M Harba; Engy V N Beshay; Marwa A Gouda; Sawsan S Shendi; Asmaa Shams El-Dein Mohamed
Journal:  J Parasit Dis       Date:  2019-07-15

4.  Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.

Authors:  Samia E Etewa; Dalia A Abo El-Maaty; Rania S Hamza; Ashraf S Metwaly; Mohamed H Sarhan; Sara A Abdel-Rahman; Ghada M Fathy; Mahmoud A El-Shafey
Journal:  J Parasit Dis       Date:  2017-12-15

Review 5.  Effects of Curcumin and Its Analogues on Infectious Diseases.

Authors:  Reza Ranjbar; Hossein Bagheri; Faezeh Ghasemi; Paul C Guest; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  The potential effects of silver and gold nanoparticles as molluscicides and cercaricides on Schistosoma mansoni.

Authors:  M A Moustafa; H S Mossalem; R M Sarhan; A A Abdel-Rahman; E M Hassan
Journal:  Parasitol Res       Date:  2018-10-03       Impact factor: 2.289

7.  Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra Bhattacharya; F J Ahmad; Mohammad Samim; M Z Abidin; A K Dinda
Journal:  Parasitol Res       Date:  2013-12-24       Impact factor: 2.289

8.  The anti-giardial effectiveness of fungal and commercial chitosan against Giardia intestinalis cysts in vitro.

Authors:  Mohammad Yarahmadi; Mahdi Fakhar; Mohammad Ali Ebrahimzadeh; Aroona Chabra; Bahman Rahimi-Esboei
Journal:  J Parasit Dis       Date:  2014-03-12

Review 9.  Therapeutic Applications of Curcumin Nanoformulations.

Authors:  Murali M Yallapu; Prashanth K Bhusetty Nagesh; Meena Jaggi; Subhash C Chauhan
Journal:  AAPS J       Date:  2015-09-03       Impact factor: 4.009

Review 10.  Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes.

Authors:  Nasrin Dashti; Mitra Zarebavani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.